pharmaphorum

JULY 7, 2024

Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice

115

115

Med Ed 101

JULY 7, 2024

JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying asleep since beginning the […] The post Wellbutrin XL Versus Bupropion SR – Insomnia Rates appeared first on Med Ed 101.

105

105

Express Pharma

JULY 7, 2024

Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders dissect the trends impacting the Vitamins, Minerals and Supplements (VMS) segment in India’s Pharma market, ranging from the focus shift from illness to wellness, emerging segments like sports nutrition, sleep products, increasing regulator oversight requiring evidence based nutraceuticals, and future innovat

102

102

FDA Law Blog: Biosimilars

JULY 7, 2024

By Gail H. Javitt — In its final rule on laboratory developed tests (LDTs) (see our prior blog here ), FDA acknowledged that “some laboratories may lack familiarity, experience, or existing infrastructure for complying with FDA requirements” and made multiple references to a “small entity compliance guidance” that the agency intended to publish to “provide additional guidance to small businesses.

Labelling 64

Labelling Communication Documentation 64

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Drug Patent Watch

JULY 7, 2024

This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

59

59

Drug Patent Watch

JULY 7, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59

59

Pharmacy Times

JULY 7, 2024

In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.

37

37